GoodRx Holdings Inc. Class A Common Stock (GDRX)
Stock · NASDAQ · Technology
$3.36as of 10/16/2026
Price chart
Active signals
GDRX Signal Track Record
How signals performed across all stocks →What GDRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 27 | +7.9% | 70% | July 30, 2026 |
| Bollinger Band Breakdown | 19 | -2.8% | 47% | September 29, 2026 |
| Bollinger Band Breakout | 20 | -4.5% | 45% | July 29, 2026 |
| 200-Day Moving Average TouchActive now | 14 | -2.4% | 36% | June 29, 2026 |
| Any 20-session window (baseline) | -1.2% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About GDRX
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, includi…
- Sector
- Technology
- Industry
- EDP Services
- Employees
- 697
- Website
- investors.goodrx.com/
Fundamentals
- 1-day range
- $3.38$3.55
- Market cap
- $1.26B
- P/E (trailing)
- 73.06
- P/E (forward)
- 9.96
- EPS (trailing)
- $0.05
- Dividend yield
- —
- Beta
- 1.69
- Avg. volume
- 1.27M
How GoodRx Holdings Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
12 analyst ratings
GoodRx Holdings Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- GDRXGoodRx Holdings Inc. Class A Common Stock$3.36▼ 4.14%Market cap $1.26BP/E 73.06$1.77$4.3
- PLTKPlaytika Holding Corp. Common Stock$2.11▼ 3.21%Market cap $1.25BP/E —$2.04$4.42
- MGRTMega Fortune Company Limited Ordinary Shares$107.55▲ 3.36%Market cap $1.31BP/E 529.72$4.04$170
- CLVTClarivate Plc Ordinary Shares$1.77▲ 1.72%Market cap $1.18BP/E —$1.42$3.87
- BRAIBraiin Limited Common Stock$4.36▼ 6.84%Market cap $1.16BP/E —$4.19$33
- UPWKUpwork Inc. Common Stock$8.43▼ 3.55%Market cap $1.16BP/E 10.73$7.44$22.84
- BRUNBoost Run Inc. Class A Common Stock$8.89▼ 11.81%Market cap $1.06BP/E 392.24$8.95$42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GDRX GoodRx Holdings Inc. Class A Common Stock | $1.26B | 73.06 | $3.36 | ▼ 4.14% | $1.77$4.3 |
| PLTK Playtika Holding Corp. Common Stock | $1.25B | — | $2.11 | ▼ 3.21% | $2.04$4.42 |
| MGRT Mega Fortune Company Limited Ordinary Shares | $1.31B | 529.72 | $107.55 | ▲ 3.36% | $4.04$170 |
| CLVT Clarivate Plc Ordinary Shares | $1.18B | — | $1.77 | ▲ 1.72% | $1.42$3.87 |
| BRAI Braiin Limited Common Stock | $1.16B | — | $4.36 | ▼ 6.84% | $4.19$33 |
| UPWK Upwork Inc. Common Stock | $1.16B | 10.73 | $8.43 | ▼ 3.55% | $7.44$22.84 |
| BRUN Boost Run Inc. Class A Common Stock | $1.06B | 392.24 | $8.89 | ▼ 11.81% | $8.95$42 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 3 Cash-Producing Stocks We Steer Clear OfYahoo · 10/6/2026
- 3 Reasons to Avoid GDRX and 1 Stock to Buy InsteadYahoo · 10/5/2026
- Full Transcript: GoodRx Holdings Q2 2026 Earnings Callbenzinga · 10/5/2026
- Full Transcript: GoodRx Holdings Q2 2026 Earnings CallBenzinga · 10/5/2026
- Amazon (AMZN) and GoodRx (GDRX) Chase Prescription Subscribers as Insurance Coverage SlipsYahoo · 10/1/2026
- 1 Value Stock to Target This Week and 2 That UnderwhelmYahoo · 9/29/2026
- 3 of Wall Street’s Favorite Stocks We Approach with CautionYahoo · 9/14/2026
Insider Activity
Insider Actions →- Fengler Justin · September 15, 2026 · Option Exercise752
- Fengler Justin · September 15, 2026 · Option Exercise2.3K
- Fengler Justin · September 15, 2026 · Tax Withholding330 @ $3.56
- Fengler Justin · September 15, 2026 · Tax Withholding1.0K @ $3.56
- Chan Thomas (TC) · September 15, 2026 · Option Exercise2.1K
- Chan Thomas (TC) · September 15, 2026 · Tax Withholding1.1K @ $3.56
- FRANCISCO PARTNERS IV, L.P. · August 26, 2026 · Sale433.1K @ $3.5
- FRANCISCO PARTNERS IV, L.P. · August 26, 2026 · Sale439.3K @ $3.5
- FRANCISCO PARTNERS IV, L.P. · August 26, 2026 · Sale210.4K @ $3.51
- FRANCISCO PARTNERS IV, L.P. · August 26, 2026 · Sale213.4K @ $3.51
- FRANCISCO PARTNERS IV, L.P. · August 25, 2026 · Sale63.2K @ $3.44
- FRANCISCO PARTNERS IV, L.P. · August 25, 2026 · Sale64.1K @ $3.44
- FRANCISCO PARTNERS IV, L.P. · August 24, 2026 · Sale71.3K @ $3.46
- FRANCISCO PARTNERS IV, L.P. · August 24, 2026 · Sale72.3K @ $3.46
- FRANCISCO PARTNERS IV, L.P. · August 21, 2026 · Sale136.4K @ $3.5
Institutional Ownership
March 31, 2026
- Total shares held
- 114.80M
- Total value held
- $213.79M
- Institutional holders
- 168
- Unknown60.08M
- Unknown4.98M
- Unknown4.46M
- Unknown4.26M
- Unknown3.53M
- Unknown3.26M
- Unknown3.10M
- Unknown2.45M
- Unknown2.11M
- Unknown1.86M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.